Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 8 | 2022 | 36 | 2.190 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 8 | 2021 | 64 | 1.890 |
Why?
|
| Interferon Regulatory Factor-1 | 5 | 2012 | 7 | 1.740 |
Why?
|
| Multiple Sclerosis | 9 | 2022 | 92 | 1.390 |
Why?
|
| Interferon-gamma | 4 | 2012 | 82 | 0.910 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 5 | 2022 | 14 | 0.760 |
Why?
|
| Myelin Sheath | 4 | 2022 | 26 | 0.720 |
Why?
|
| Neuromyelitis Optica | 3 | 2019 | 5 | 0.670 |
Why?
|
| Mice | 12 | 2022 | 1352 | 0.600 |
Why?
|
| Apoptosis | 3 | 2010 | 209 | 0.600 |
Why?
|
| Animals | 14 | 2022 | 3503 | 0.580 |
Why?
|
| Demyelinating Diseases | 2 | 2022 | 14 | 0.550 |
Why?
|
| Aquaporin 4 | 3 | 2019 | 6 | 0.550 |
Why?
|
| Signal Transduction | 4 | 2020 | 437 | 0.480 |
Why?
|
| Immunologic Factors | 6 | 2022 | 26 | 0.480 |
Why?
|
| Inflammation | 3 | 2018 | 267 | 0.450 |
Why?
|
| Cell Differentiation | 3 | 2022 | 132 | 0.440 |
Why?
|
| Natalizumab | 4 | 2022 | 20 | 0.400 |
Why?
|
| Aquaporins | 1 | 2012 | 7 | 0.400 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 10 | 0.390 |
Why?
|
| Cells, Cultured | 6 | 2020 | 512 | 0.360 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2011 | 1 | 0.350 |
Why?
|
| Immunomodulation | 1 | 2011 | 7 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 6 | 2022 | 408 | 0.350 |
Why?
|
| Neuroglia | 1 | 2011 | 47 | 0.340 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 2 | 0.330 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2007 | 4 | 0.320 |
Why?
|
| Stem Cells | 1 | 2010 | 37 | 0.320 |
Why?
|
| Mice, Transgenic | 4 | 2012 | 214 | 0.300 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 115 | 0.290 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 106 | 0.280 |
Why?
|
| Repressor Proteins | 1 | 2006 | 38 | 0.250 |
Why?
|
| Carrier Proteins | 1 | 2006 | 96 | 0.240 |
Why?
|
| Th17 Cells | 2 | 2021 | 29 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2018 | 99 | 0.220 |
Why?
|
| Wound Healing | 1 | 2005 | 157 | 0.210 |
Why?
|
| Female | 13 | 2022 | 14734 | 0.210 |
Why?
|
| Filgrastim | 2 | 2019 | 4 | 0.200 |
Why?
|
| Cardiac Glycosides | 1 | 2022 | 1 | 0.200 |
Why?
|
| Humans | 15 | 2022 | 25967 | 0.190 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 1 | 0.180 |
Why?
|
| Interleukin-17 | 1 | 2021 | 16 | 0.180 |
Why?
|
| Caspase 1 | 2 | 2012 | 13 | 0.180 |
Why?
|
| Flow Cytometry | 2 | 2011 | 106 | 0.170 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2020 | 15 | 0.170 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2020 | 25 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2011 | 297 | 0.160 |
Why?
|
| Semaphorin-3A | 1 | 2018 | 1 | 0.150 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Neuropilin-1 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Central Nervous System | 2 | 2010 | 52 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 577 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 37 | 0.150 |
Why?
|
| JC Virus | 1 | 2019 | 97 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2019 | 111 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 178 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2014 | 13 | 0.110 |
Why?
|
| Middle Aged | 6 | 2019 | 8772 | 0.100 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2012 | 8 | 0.100 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 5 | 0.100 |
Why?
|
| Male | 7 | 2020 | 14277 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2012 | 62 | 0.100 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 153 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 190 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 71 | 0.100 |
Why?
|
| Rabbits | 1 | 2012 | 179 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2010 | 168 | 0.090 |
Why?
|
| Adult | 6 | 2020 | 7662 | 0.090 |
Why?
|
| Electrophoresis | 1 | 2011 | 3 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 142 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 55 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 368 | 0.080 |
Why?
|
| Janus Kinases | 1 | 2010 | 1 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 49 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 100 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2010 | 75 | 0.080 |
Why?
|
| Antilymphocyte Serum | 2 | 2019 | 3 | 0.080 |
Why?
|
| Cyclophosphamide | 2 | 2019 | 46 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 157 | 0.070 |
Why?
|
| Rats | 1 | 2010 | 640 | 0.070 |
Why?
|
| Pericytes | 1 | 2007 | 6 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2007 | 8 | 0.070 |
Why?
|
| Chemokines | 1 | 2007 | 18 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2007 | 44 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2007 | 15 | 0.070 |
Why?
|
| Disease Progression | 2 | 2019 | 655 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 1 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2007 | 80 | 0.060 |
Why?
|
| Cell Survival | 1 | 2006 | 116 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 1059 | 0.060 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 4 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 162 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 153 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 268 | 0.050 |
Why?
|
| Young Adult | 2 | 2019 | 1941 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 318 | 0.050 |
Why?
|
| Cuprizone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Digoxin | 1 | 2022 | 1 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2022 | 5 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2021 | 26 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2020 | 17 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2020 | 38 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 120 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 225 | 0.040 |
Why?
|
| Hematologic Agents | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2019 | 4 | 0.040 |
Why?
|
| Rituximab | 1 | 2019 | 39 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2019 | 33 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2019 | 63 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 156 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 300 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 18 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 21 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 488 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 297 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 605 | 0.040 |
Why?
|
| Macrophages | 1 | 2018 | 101 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 1701 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1391 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 1250 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 2014 | 20 | 0.030 |
Why?
|
| Adolescent | 1 | 2019 | 2099 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 3399 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 1569 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3358 | 0.020 |
Why?
|
| Plasma | 1 | 2010 | 15 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 33 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 55 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 58 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 55 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 93 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 79 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 466 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 473 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 544 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 1806 | 0.010 |
Why?
|